-65%

est. 2Y upside i

Healthcare

Rank

#3767

Sector

HealthTech

Est. Liquidity

~2Y

Data Quality

Data: Medium

Bamboo Health operates in an attractive HealthTech market with strong gross margins and a significant network.

Last updated: March 10, 2026

Bull (15%)+75%

Strong adoption of new products like Bamboo Bridge and successful expansion into new states/health systems drives revenue growth to 20%+ YoY, reaching ~$560M by 2028. This accelerated growth and market leadership in specific niches justify a higher valuation of $3.5B.

Base (48%)+20%

Bamboo Health maintains its competitive position in care coordination and behavioral health, growing revenue steadily at its current 13% YoY rate to ~$480M by 2028. Valuation increases modestly to $2.4B, reflecting stable performance and continued market presence.

Bear (37%)-40%

Increased competition from major EHR vendors like Epic Systems, coupled with slower-than-expected adoption of new solutions and potential regulatory headwinds in behavioral health funding, leads to decelerated growth or flat revenue. A down round or acquisition at a lower multiple results in a $1.2B valuation, significantly impacting common stock value given the $414M in liquidation preferences.

Est. time to liquidity~2.0 years

Preference Stack Risk

high

Investors hold $414M in liquidation preferences, which represents 20.7% of the estimated $2.0B current valuation.

Dilution Risk

moderate

As a late-stage company, further significant equity dilution is possible but less likely than in earlier stages, though future funding rounds could still impact common share value.

Secondary Liquidity

limited

There is no indication of active secondary markets or tender offers, meaning liquidity for employee equity is likely limited until a major exit event.

Questions to Ask at the Interview

Strategic questions based on PatientPing's data — designed to show you've done your homework.

  • 1

    “How does Bamboo Health plan to differentiate its care coordination and behavioral health platforms against the expanding offerings of major EHR vendors like Epic Systems, especially as they integrate more functionalities into their core products?”

  • 2

    “With a current revenue of ~$375M and 13% YoY growth, what are the key strategic initiatives to accelerate growth towards the higher end of the TAM's weighted growth of 13-15% or beyond, particularly in the Care Management Solutions segment?”

  • 3

    “Given the company's late-stage funding and the significant total funding raised, what is the anticipated timeline and preferred path to a liquidity event (IPO or acquisition) for common shareholders, and what are the company's plans regarding potential secondary liquidity?”

Community

Valuation Sentiment

Our model estimates -65% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.